First wave of COVID-19 pandemic in Madrid: handling the unexpected in a tertiary hospital
pdf

Keywords

COVID-19
SARS-CoV-2
Pandemic
Epidemic curve

Abstract

The COVID-19 pandemic was declared on March 11th, 2020. By the end of January, the first imported cases were detected in Spain and, by March, the number of cases was growing exponentially, causing the implementation of a national lockdown. Madrid has been one of the most affected regions in terms of both cases and deaths. The aim of this study is to describe the epidemic curve and the epidemiological features and outcomes of COVID-19 patients hospitalized in La Paz University Hospital, a tertiary hospital located in Madrid. We included confirmed and probable COVID-19 cases admitted to our centre from February 26th to June 1st, 2020. We studied trends in hospitalization and ICU admissions using joinpoint regression analysis. A sample of 2970 patients was obtained. Median age was 70 years old (IQR 55 – 82) and 54.8% of them were male. ICU admission rate was 8.7% with a mortality rate of 45.7%. Global CFR was 21.8%. Median time from symptom onset to death was 14 days (IQR 9 – 22). We detected an admissions peak on March 21st followed by a descending trend, matching national and regional data. Age and sex distribution were comparable to further series nationally and in western countries.

https://doi.org/10.15167/2421-4248/jpmh2022.63.3.2037
pdf

References

1. Coronavirus Disease (COVID-19) Situation Reports. Accessed June 1, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
2. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. Published online March 18, 2020. Accessed June 1, 2020. http://www.ncbi.nlm.nih.gov/nuccore/MN908947.3
3. Coronavirus (COVID-19) events as they happen. Accessed June 1, 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
4. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DSC, Du B, Li L, Zeng G, Yuen K-Y, Chen R, Tang C, Wang T, Chen P, Xiang J, Li S, Wang J, Liang Z, Peng Y, Wei L, Liu Y, Hu Y, Peng P, Wang J, Liu J, Chen Z, Li G, Zheng Z, Qiu S, Luo J, Ye C, Zhu S, Zhong N. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032
5. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study - The Lancet. Accessed October 9, 2020. https://www.thelancet.com/journals/lancet/article/PIIS0140-67362030211-7/fulltext
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi:10.1001/jama.2020.1585
7. Lippi G, Mattiuzzi C, Sanchis‐Gomar F, Henry BM. Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China. J Med Virol. 2020;92(10):1759-1760. doi:10.1002/jmv.25860
8. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB, Hoffman KL, Alshak MN, Li HA, Wehmeyer GT, Rajan M, Reshetnyak E, Hupert N, Horn EM, Martinez FJ, Gulick RM, Safford MM. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. Published online April 17, 2020. doi:10.1056/NEJMc2010419
9. ECDC. Case definition and European surveillance for COVID-19. European Centre for Disease Prevention and Control (ECDC). Published March 2, 2020. Accessed June 1, 2020. https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-human-infection-novelcoronavirus-2019-ncov
10. Chien L-C, Lin R-T. COVID-19 Outbreak, Mitigation, and Governance in High Prevalent Countries. Ann Glob Health. 2020;86(1):119. doi:10.5334/aogh.3011
11. NIH. Joinpoint Trend Analysis Software. US National Cancer Institute. Published 2015. Accessed June 25, 2020. https://surveillance.cancer.gov/joinpoint/
12. España. Real Decreto 463/2020, de 14 de Marzo, Por El Que Se Declara El Estado de Alarma Para La Gestión de La Situación de Crisis Sanitaria Ocasionada Por El COVID-19. Boletín Oficial Del Estado, 14 de Marzo de 2020, Núm. 67, Pp. 25390 a 25400. https://www.boe.es/buscar/act.php?id=BOE-A-2020-3692
13. Informe Situación a 1 de Junio 2020. Dirección General de Salud Pública. Servicio Madrileño de Salud y Hospitales Privados. Consejería de Sanidad. https://www.comunidad.madrid/sites/default/files/doc/sanidad/200601_cam_covid19.pdf
14. Equipo COVID-19. RENAVE. Análisis de Los Casos de COVID-19 Notificados a La RENAVE Hasta El 10 de Mayo En España a 29 de Mayo de 2020. Equipo COVID-19. CNE. CNM (ISCIII) https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20n%C2%BA%2033.%20An%C3%A1lisis%20de%20los%20casos%20de%20COVID-19%20hasta%20el%2010%20de%20mayo%20en%20Espa%C3%B1a%20a%2029%20de%20mayo%20de%202020.pdf
15. Madrid. ORDEN 338/2020, de 9 de Marzo, de La Consejería de Sanidad, Por La Que Se Adoptan Medidas Preventivas y Recomendaciones de Salud Pública En La Comunidad de Madrid Como Consecuencia de La Situación y Evolución Del Coronavirus (COVID-19). Boletín Oficial de La Comunidad de Madrid, 10 de Marzo de 2020, Núm. 59. https://www.bocm.es/boletin/CM_Orden_BOCM/2020/03/10/BOCM-20200310-1.PDF
16. Giesen C, Diez-Izquierdo L, Saa-Requejo CM, Lopez-Carrillo I, Lopez-Vilela CA, Seco-Martinez A, Prieto MTR, Malmierca E, Garcia-Fernandez C, COVID Epidemiological Surveillance and Control Study Group. Epidemiological characteristics of the COVID-19 outbreak in a secondary hospital in Spain. Am J Infect Control. Published online July 11, 2020. doi:10.1016/j.ajic.2020.07.014
17. Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, Lumbreras-Bermejo C, Ramos-Rincón JM, Roy-Vallejo E, Artero-Mora A, Arnalich-Fernández F, García-Bruñén JM, Vargas-Núñez JA, Freire-Castro SJ, Manzano-Espinosa L, Perales-Fraile I, Crestelo-Viéitez A, Puchades-Gimeno F, Rodilla-Sala E, Solís-Marquínez MN, Bonet-Tur D, Fidalgo-Moreno MP, Fonseca-Aizpuru EM, Carrasco-Sánchez FJ, Rabadán-Pejenaute E, Rubio-Rivas M, Torres-Peña JD, Gómez-Huelgas R. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clin Esp. Published online September 9, 2020. doi:10.1016/j.rceng.2020.07.003
18. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study | The BMJ. Accessed October 9, 2020. https://www.bmj.com/content/369/bmj.m1985
19. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052-2059. doi:10.1001/jama.2020.6775
20. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3
21. Population classified according to place of birth. Madrid Statistics Institute. Accessed June 1, 2020. http://www.madrid.org/iestadis/fijas/estructu/demograficas/padron/pc19i1.htm
22. Sze S, Pan D, Nevill CR, Gray LJ, Martin CA, Nazareth J, Minhas JS, Divall P, Khunti K, Abrams KR, Nellums LB, Pareek M. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine. Published online November 2020:100630. doi:10.1016/j.eclinm.2020.100630
23. Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z